AstraZeneca gets nod to launch cancer drug – Times of India
NEW DELHI: AstraZeneca Pharma India has received permission to import for sale and distribution of Durvalumab 120 mg/2.4 mL and…
AstraZeneca aims for $80 billion in sales by 2030
AstraZeneca Plc aims to almost double sales to $80 billion by 2030 as Chief Executive Officer Pascal Soriot seeks to…